Publications

MicroRNA as key players in skin regeneration and anti-aging pathways

October 12, 2026

This review highlights current knowledge of miRNA-mediated regulation in skin regeneration and aging and synthesizes recent findings on their individual functions in these biological processes.

Glycemia reprograms substrate transport and shapes divergent stress responses in differentiating H9c2 cells

October 5, 2026

This work highlights metabolic homeostasis as a critical determinant of cellular stress resilience and provides mechanistic insight into how early metabolic stress shapes cardiomyocyte vulnerability.

Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies

August 7, 2026

This review advances the hypothesis that benzodiazepines should be preferentially substituted by alternative sedative strategies in septic shock and critical illness, and that ACBP/DBI is a mechanistically grounded biomarker and therapeutic target linking sedation biology, immune dysfunction and accelerated aging.

Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages

July 7, 2026

Our findings indicate that the suppression of ovarian cancer by Triptolide is mediated in part through its capacity to reprogram TAMs via the Nrf2 pathway.

Polyamine-mediated inhibition of ferroptosis contributes to geroprotection

July 3, 2026

This editorial highlights unified model in which spermidine-driven autophagy and spermine-mediated ferroptosis inhibition cooperate to preserve tissue homeostasis and healthspan.

The IRE1α-XBP1s-NFκB axis controls cell survival and epithelial differentiation under osmotic stress through arachidonic acid metabolism activation

April 27, 2026

Our findings highlight a central role for the IRE -XBP1s-NFB signaling axis in coordinating cell stress responses and epithelial differentiation through AA metabolism activation.

Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential

March 9, 2026

This review meticulously dissects CNPY2’s structural characteristics, expression patterns, and biological functions across various disorders, emphasizing its role on tumor initiation, microenvironmental stress, and chemoresistance, and evaluating its potential as a therapeutic target.

Antifungal peptides: from modes of action to synergistic and immunologic potential

January 30, 2026

This review underscores the potential of AFPs as viable candidates for the development of next-generation antifungal therapies, advocating their multimodal advantage that spans beyond standalone activity, including their synergistic and immune-regulatory potential.

Reversal of Cushing syndrome by antibody-mediated neutralization of ACBP/DBI

January 26, 2026

This study investigates the therapeutic potential of ACBP/DBI neutralization in a well-established murine model of CS, positioning ACBP/DBI neutralization as a viable therapeutic strategy for established CS.

Burning fat with cysteine depletion

November 13, 2025

This News & Thouhgts article comments on two complementary articles by Varghese et al and Lee et al showing that cysteine depletion through combined dietary and genetic means in mice evokes a unique stress response in the liver to amplify these metabolic outcomes and offer a potentially new treatment option for obesity.

Next